European Medicines Agency welcomes publication of the Clinical Trials Regulation
EMA: 28/05/2014 The European Medicines Agency (EMA) welcomes the publication of the Clinical Trials Regulation in the Official Journal of the European Union (EU). This legislation will open up a new era for the conduct of clinical trials in the EU, ensuring that Europe remains an attractive centre for clinical research. This will foster European competitiveness and […]
Racial diversity crucial to trials of drugs, treatments
Sfgate: Tuesday, May 20, 2014 As a nurse practitioner, Phyllis Howardunderstands the value of clinical trials in testing new drugs or treatment protocols. But as an African American woman, she was leery about the idea of being a test subject. “I considered it being experimented on,” said Howard, 56, of her initial reaction to a suggestion by her […]
Hispanic Accrual on Randomized Cancer Clinical Trials: A Call to Arms
JCO May 19, 2014 The Hispanic population is the fastest growing demographic group in the United States and is expected to triple from 46.7 million to 132.8 million by 2050.1 Hispanics suffer from major health dispar- ities, and they have low participation in cancer screening and preven- tion programs and higher incidence rates for cancers of […]
High Incarceration Rates Among Black Men Enrolled In Clinical Studies May Compromise Ability To Identify Disparities
Health Aff May 2014 In 1978 the federal government restricted research on prison and jail inmates in medical studies, the result of decades of unethical research in correctional institutions. We evaluated the impact this policy has had on studies of health outcomes in minority populations, particularly studies involving black men, who are disproportionately incarcerated. Specifically, we […]
A brave new world – ‘research with’ not ‘research on’ patients
Biomedcentral.: May 20, 2014 ‘On the 20th of May 1747, I took twelve patients in the scurvy, on board the Salisbury at sea. Their cases were as similar as I could have them.’ James Lind This is a description of one of the first ever clinical trials, investigating the impact of citrus fruit on scurvy. According to Lind, scurvy […]
Health and financial analysis reinforces NIH’s decision to fund Women’s Health Initiative
National Institutes of Health (NIH): May 5, 2014 An in-depth analysis of final data from one of the Women’s Health Initiative (WHI) Postmenopausal Hormone Therapy Trials has found that the investment in WHI resulted in a return of $140 in net economic value for each dollar invested in the trial. The WHI, sponsored by the National […]
More than 100 New Medicines in Development to Treat Mental and Addictive Disorders
Phrma: May 5, 2014 Washington, D.C. (May 5, 2014) — America’s biopharmaceutical research companies currently are developing 119 novel new medicines to help improve the lives of the estimated 61.5 million Americans that are affected by mental health disorders, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). These medicines in development – all […]